BenQ Materials Corporation

BenQ Materials Corporation produces a range of medical devices, including negative pressure wound therapy systems like the AnsCare SIMO NPWT System, which helps manage wounds by applying controlled pressure. It also manufactures chitin-based wound dressings such as AnsCare ChitoClot Gauze (available in prescription and over-the-counter versions) and AnsCare ChitoClot Pads, designed for clotting and wound care. Additionally, the company supplies contact lenses under the miacare brand, including daily wear and single-use variants with advanced materials like EautraSil Plus.

BenQ Materials Corporation is headquartered in Taiwan. The company’s location in Taiwan influences its regulatory compliance processes, particularly for markets like the EU and the US, where devices must meet specific standards and undergo registration or clearance procedures.

BenQ Materials Corporation’s medical devices are listed in the EU’s eudamed registry, which is the centralised database for medical devices in the European Union. Additionally, some of its devices have undergone FDA 510(k) clearance in the United States, meaning they are included in the FDA’s premarket notification database for devices deemed substantially equivalent to previously cleared products.

BenQ Materials Corporation’s devices are classified under different regulatory categories depending on their risk level and intended use. For example, some of its products fall under Class I (low-risk devices), while others are classified as Class II (moderate-risk devices). There are also devices marked as unclassified (U), which may require additional evaluation or fall outside standard classification schemes. These classifications determine the regulatory pathways, such as registration, premarket notification, or conformity assessment procedures, that the devices must follow.